MIRA INFORM REPORT

 

 

Report Date :

25.07.2013

 

IDENTIFICATION DETAILS

 

Name :

EMCURE PHARMACEUTICALS LIMITED

 

 

Registered Office :

‘Emcure House’, T – 184, MIDC, Bhosari, Pune – 411026, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012 (Profit and Loss A/c)

 

 

Date of Incorporation :

16.04.1981

 

 

Com. Reg. No.:

25-024251

 

 

Capital Investment / Paid-up Capital :

Rs. 351.657 Millions (As on 31.03.2011)

 

 

CIN No.:

[Company Identification No.]

U24231PN1981PLC024251

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

PNEE00094D

 

 

PAN No.:

[Permanent Account No.]

AAACE4574C

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Marketing of Pharmaceuticals such as Antibiotics, Herbal, Bacteriological and Biological Products.

 

 

No. of Employees :

4500 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (54)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 16447000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject is a well established company having a good track record.

 

The company has shown better improvement in its operations and profits during 2012. The balance sheet is not available.

 

However, trade relations are reported as decent. Business is active. Payment terms are regular and as per commitments.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

A+ [Long Term Bank Facilities]

Rating Explanation

Adequate degree of safety and low credit risk.

Date

July 2013

 

 

Rating Agency Name

CARE

Rating

A1 [Short Term Bank Facilities]

Rating Explanation

Very strong degree of safety and lowest credit risk.

Date

July 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Gaurav Pancholia

Designation :

Finance Manager

Contact No.:

91-20-30610000

Date :

23.07.2013

 

 

LOCATIONS

           

Registered Office :

‘Emcure House’, T – 184, MIDC, Bhosari, Pune – 411026, Maharashtra, India

Tel. No.:

91-20-30610000

Fax No.:

91-20-30610111

E-Mail :

corporate@emcure.co.in

gaurav.pancholia@emcure.co.in

dixit@blackstone.com

Website :

http://www.emcure.co.in

Area :

50000 Sq. ft.

Location :

Owned

 

 

Manufacturing Units :

API Manufacturing

Plot No. D – 24, M.I.D.C., Kurkumbh, Taluka Daund, District Pune - 413802, Maharashtra, India

Tel No.: 91-2117-305000/ 235742

Fax No.: 91-2117-235743

 

Formulations – Injectables

Plot P – 1, MIDC, Hinjewadi, Pune – 411057, Maharashtra, India

Tel No.: 91-20-39821300

Fax No.: 91-20-39821400

 

Formulations – Solids

1.       C – 10/12, M.I.D.C., Bhosari, Pune – 411026, Maharashtra, India

 

2.       Plot P-II, MI.D.C. Hinjwadi, Pune 411057, Maharashtra, India

Tel No.: 91-20-39821300

Fax No.: 91-20-39821340

 

Small Batch Manufacturing

Plot P-II, IT-BT Park, MI.D.C. Hinjwadi, Pune -  411057, Maharashtra, India

Tel No.: 91-20-39821300

Fax No.: 91-20-39821444

 

 

R and D Centers :

API R and D

Plot 12/2, F – II Block, M.I.D.C., Pimpri, Pune – 411018, Maharashtra, India

Tel No.: 91-20-30613000

Fax No.: 91-20-30613056

 

Plot P-II, IT-BT Park M.I.D.C. Hinjwadi, Pune -  411057, Maharashtra, India

Tel No.: 91-20-39821350

Fax No.: 91-20-39821445

 

Formulation R and D

T 184, M.I.D.C, Bhosari, Pune – 411026, Maharashtra, India

Tel No.: 91-20-30610000

Fax No.: 91-20-30610222

 

Biotechnology R and D

Plot No. I, IT-BT Park M.I.D.C. Hinjwadi, Pune - 411057, Maharashtra, India

Tel No.: 91-20-39821300

Fax No.: 91-20-39821441

 

 

DIRECTORS

 

AS ON 10.08.2012

 

Name :

Mr. Hamayun Raja Dhanrajgir

Designation :

Director

Address :

Flat No. F – 37/38, Dhanraj Mahal, CSM Road, Apollo Bunder, Mumbai – 400039, Maharashtra, India

Date of Birth/Age :

02.12.1936

Date of Appointment :

23.09.2000

DIN No.:

00004006

 

 

Name :

Dr. Mukund Keshav Gurjar

Designation :

Whole Time Director

Address :

Bungalow C – II / 2, NCL Colony, Pashan Road, Pune – 411008, Maharashtra, India

Date of Birth/Age :

28.08.1952

Qualification :

M. Sc., Ph. D.

Date of Appointment :

28.08.2012

Voter ID No.:

DRD0732172

DIN No.:

00026843

 

 

Name :

Mr. Mahesh Nathalal Shah

Designation :

Whole Time Director (Technical)

Address :

303, Abhinav Sankul, Plot No. 1A, Survey No. 132, Aundh, Pune – 411007, Maharashtra, India

Date of Birth/Age :

03.10.1953

Qualification :

M. Sc.

Date of Appointment :

15.06.2011

Voter ID No.:

MT/ 42/ 246/ 0777545

DIN No.:

00118341

 

 

Name :

Mr. Satish Ramanlal Mehta

Designation :

Managing Director

Address :

4, Mumbai – Pune Road, Kirkee, Pune – 411003, Maharashtra, India

Date of Birth/Age :

13.01.1951

Date of Appointment :

01.04.2012

Qualification :

M. Sc., M.B.A. [IIMA]

Voter ID No.:

FGD0962068

DIN No.:

00118691

 

 

Name :

Mr. Arunkumar Purushotamalal Khanna

Designation :

Whole Time Director

Address :

Clover Hills, Bungalow No.63, Nibm Road, Kondhwa, Pune – 411048, Maharashtra, India

Date of Birth/Age :

09.07.1952

Qualification :

B. Sc, M.A. (Eco)

Date of Appointment :

05.01.2010

DIN No.:

00121686

 

 

Name :

Mr. Berjis Minoo Desai

Designation :

Director

Address :

Yezerina II, 740/ 741, Parsi Colony Road No. 5, Dadar, Mumbai – 400014, Maharashtra, India

Date of Birth/Age :

02.08.1956

Qualification :

LLM

Date of Appointment :

03.04.1997

DIN No.:

00153675

 

 

Name :

Mr. Shreekant Krushnaji Bapat

Designation :

Director

Address :

Yashodhan, II Floor, United Western CHS, Karve Nagar, Pune - 411052, Maharashtra, India

Date of Birth/Age :

06.10.1937

Date of Appointment :

26.06.1999

DIN No.:

00621568

 

 

Name :

Mr. Amit Mahendrakumar Dixit

Designation :

Nominee Director

Address :

Thakur Niwas, Flat No. 21, 173, Jamshedji Tata Road, Churchgate, Mumbai – 400020, Maharashtra, India

Date of Birth/Age :

26.01.1973

Date of Appointment :

01.03.2011

Qualification :

MBA, MS, B. Tech.

DIN No.:

01798942

 

 

Name :

Mr. Marvin Stanly Samson

Designation :

Director

Address :

752 Riverton Road, Moorestown, New Jersey – 08057

Date of Birth/Age :

20.06.1941

Date of Appointment :

27.08.2007

DIN No.:

01824691

 

 

Name :

Mr. Vikas Madan Thapar

Designation :

Alternate Director

Address :

Prasanna 4 Mumbai Pune Road, Pune-411003, Maharashtra, India

Date of Birth/Age :

27.04.1974

Qualification :

B. Sc., MBA (Finance and Operation)

Date of Appointment :

27.01.2012

DIN No.:

02617012

 

 

Name :

Mr. Girish Laxmikant Telang

Designation :

Director

Address :

401, Sagar Dardhan, 4th Floor, Worli Sea Face, Mumbai – 400030, Maharashtra, India

Date of Birth/Age :

28.11.1949

Date of Appointment :

27.04.2012

DIN No.:

00455125

 

 

Name :

Mr. Mukund Pandurang Ranade

Designation :

Whole-Time Director

Address :

C-503, Pride Panorama Senapati Bapat Marg, Pune – 411016, Maharashtra, India 

Date of Birth/Age :

30.04.1956

Date of Appointment :

29.06.2012

DIN No.:

00109845

 

 

KEY EXECUTIVES

 

Name :

Mr. Kedar Purshottam Phadke

Designation :

Secretary

Address :

D-4, Arvind Complex, Hingne Khurd Sinhgad Road, Pune-411051, Maharashtra, India

Date of Birth/Age :

31.08.1966

Date of Appointment :

19.11.2010

Pan No.:

ABQPP3732P

 

 

Name :

Mr. Gaurav

Designation :

Finance Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 19.07.2011

 

NOTE: SHAREHOLDING DETAILS FILE ATTACHED.

 

 

AS ON 10.08.2012

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

15.39

Directors or relatives of directors

 

53.89

Other top fifty shareholders

 

30.72

TOTAL

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Marketing of Pharmaceuticals such as Antibiotics, Herbal, Bacteriological and Biological Products.

 

 

Products :

Products Description

Item Code No.

 

Medicaments (Pharmaceutical products)

3004

 

 

Brand Names :

“EMCURE”

 

 

Exports :

 

Products :

Finished Goods

Countries :

USA

 

 

Imports :

 

Products :

Raw material

Countries :

·         USA

·         China

 

 

Terms :

 

Selling :

Credit

 

 

Purchasing :

Credit and Depend

 

 

PRODUCTION STATUS [AS ON 31.03.2011]

 

Particulars

Unit

Licensed Capacity

(In Lakhs)

Installed Capacity

(In Lakhs)

Actual Production

(In Lakhs)

 

 

 

 

 

Capsules

Numbers

10000.00

10750.00

1438.42

Tablets

Numbers

50000.00

68395.00

47689.51

API

Kilograms

NA

5.97

2.00

Injectibles

Vials

NA

1570.00

146.83

Liquid

Bottle

NA

237.60

97.37

Ointments

Tubes

--

--

56.23

Others

--

--

--

32.47

 

 

GENERAL INFORMATION

 

Customers :

End Users

 

 

No. of Employees :

4500 (Approximately)

 

 

Bankers :

·         Bank of Maharashtra, Tejsingh Building, 35/B, Mumbai Pune Highway, Depodi, Pune – 411012, Maharashtra, India

 

·         The Saraswat Co-operative Bank Limited, Nana Chowk, Bombay – 400007, Maharashtra, India

 

·         Export –Import Bank of India, Centre One Building, 21st Floor, World Trade Centre Complex, Cuffe Parade, Mumbai-400005, Maharashtra, India

 

·         Axis Bank Limited, 2nd Floor, E Axis House, Bombay Dyeing Mill Compound, P. B. Marg, Worli, Mumbai-400025, Maharashtra, India

 

·         ABN Amro Bank N.V., 327, M.G. Road Camp, Pune-411001, Maharashtra, India

 

·         The Bank of Maharashtra Limited, Lokmangal, 1501, Shivaji Nagar, Pune – 411005, Maharashtra, India

 

·         Housing Development Finance Corporation Limited, Ramon House, 169, Backbay Reclamation, HT Parekh Marg, Mumbai-400020, Maharashtra, India

 

·         State Bank of India, Industrial Finance Branch, Tara Chamber, 2nd Floor, Mariaai Police Chowky, Pune-Mumbai Highway, Wakdewadi, Pune-411003, Maharashtra, India

 

·         Indusind Bank Limited, 2401, Gen Timmayya Road, Contonment, Pune-411001, Maharashtra, India

 

·         BNP Paribas Bank, French Bank Building, 62, Homji Street, Fort, Mumbai-400001, Maharashtra, India

 

 

Facilities :

Secured Loans

31.03.2011

 

31.03.2010

 

 

[Rs. in Millions]

Rupee term loans banks secured

762.580

1221.764

Rupee term loans financial institutions secured

3531.146

2237.969

Rupee term loans others secured

27.674

25.821

 

 

 

Total

 

4321.400

3485.554

 

NOTE:

 

·         1. Secured by hypothecation of stock-in-trade and book debts.2. Secured by equitable/ registered mortgage of land and building situated at M.I.D.C., Hinjewadi, Kurkumbh , Pimpri, Pune and SIDCO, Jammu and hypothecation of movable fixed assets situated at M.I.D.C Bhosari, Hinjewadi, Kurkumbh, Pimpri, Pune and SIDCO, Jammu.

 

·         [Including Interest Accrued and Due Rs. 43.543 Millions [Repayable within one year - Rs.988.500 Millions].1. Secured by hypothecation of stock-in-trade and book debts.2. Secured by equitable/ registered mortgage of land and building situated at M.I.D.C., Hinjewadi, Kurkumbh , Pimpri, Pune and SIDCO, Jammu and hypothecation of movable fixed assets situated at M.I.D.C Bhosari, Hinjewadi, Kurkumbh, Pimpri, Pune and SIDCO, Jammu.

 

·         Secured by assets acquired on hire purchase

 

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Price Waterhouse and Company

Chartered Accountants

Address :

252, Veer Savarkar Marg, Shivaji Park, Dadar, Mumbai - 400021, Maharashtra, India

PAN No:

AAEFP3641G

 

 

Subsidiaries :

·         Emcure Brasil Representacao Commercial Farmaceutica Ltda

·         Emcure Nigeria Limited

·         Emcure Pharmaceutical Mena FZ LLC

·         Emcure Pharmaceutical South Africa Pty Limited

·         Emcure Pharmaceuticals USA Inc.

·         Gennova Biopharmaceuticals Limited

      CIN No.: U24231PN2001PLC016253

·         Heritage Pharma Holdings Inc.

·         Zuventus Healthcare Limited

      CIN No.: U85320PN2002PTC018324

·         Emcure Infotech Limited

      CIN No.: U72100PN2000PTC015368

·         Emcure Pharmaceuticals Holdings Inc. (Merged with Heritage Pharma Holdings Inc. on April 29, 2011) 

 

 

Step-Down Subsidiary :

·         Heritage Pharmaceuticals Inc (Subsidiary of Heritage Pharma Holding Inc)

 

 

Other Related Parties :

·         Falcon Enterprises

·         H.M. Sales Corporation

·         Uth Beverages Factory Private Limited

·         Uth Healthcare Private Limited

·         Uth Wellness Products Limited

 

 

CAPITAL STRUCTURE

 

AFTER 10.08.2012

 

Authorised Capital: Rs. 1200.000 Millions

 

Issued, Subscribed & Paid-up Capital: Rs. 452.130 Millions

 

 

AS ON 31.03.2011

 

Authorised Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

40000000

Equity Shares

Rs. 10/- each

Rs. 400.000 Millions

20000000

Preference Shares

Rs. 10/- each

Rs. 200.000 Millions

 

Total

 

Rs. 600.000 Millions

 

Issued, Subscribed & Paid-up Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

35165689

Equity Shares

Rs. 10/- each

Rs.351.657 Millions

 

 

 

 

 

NOTES:

 

OF THE ABOVE:

 

1. 24,014,046 equity shares were allotted as fully paid-up bonus shares by way of capitalization of Reserves.

 

2. 967,498 equity shares have been issued as fully paid-up shares pursuant to the Scheme of Amalgamation for consideration other than cash.

 

3. During the year 4,300,154 Equity Shares have been issued as fully paid up shares pursuant to conversion of optionally convertible redeemable preference shares into equity shares of Rs. 10 each]


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

351.657

487.971

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

3760.134

3161.711

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

4111.791

 3649.682

LOAN FUNDS

 

 

 

1] Secured Loans

 

4321.400

3485.554

2] Unsecured Loans

 

285.248

200.119

TOTAL BORROWING

 

4606.648

3685.673

DEFERRED TAX LIABILITIES

 

424.911

190.512

 

 

 

 

TOTAL

 

9143.350

7525.867

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

5153.271

3543.943

Capital work-in-progress

 

933.930

1754.662

 

 

 

 

INVESTMENT

 

776.272

770.561

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
1623.466

1344.737

 

Sundry Debtors

 
1753.753

1416.905

 

Cash & Bank Balances

 
109.750

44.950

 

Other Current Assets

 
155.215

103.939

 

Loans & Advances

 
1594.183

1437.479

Total Current Assets

 
5236.367

4348.010

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditor

 
1856.797

1715.220

 

Other Current Liabilities

 
909.615

1028.018

 

Provisions

 
190.078

148.071

Total Current Liabilities

 
2956.490

2891.309

Net Current Assets

 
2279.877

1456.701

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.000

 

 

 

 

TOTAL

 

9143.350

7525.867

 

Note: Balance Sheet for the year 2012 is not available only Profit and Loss A/c is available.


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

12367.500

9557.920

7659.622

 

 

Other Income

181.810

134.060

202.809

 

 

TOTAL                                     (A)

12549.310

9691.980

7862.431

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

5077.380

4119.440

 

 

Purchases of stock-in-trade 

553.420

237.530

 

 

 

Changes in Inventories of Finished Goods, Work-in-progress and stock-in-trade

(169.150)

(145.220)

4747.448

 

 

Employee benefit Expenses

1907.960

1543.890

 

 

 

Other Expenses

2739.090

2262.900

 

 

 

Exceptional Item

0.170

0.000

 

 

 

TOTAL                                     (B)

10108.870

8018.540

4747.448

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

2440.440

1673.440

3114.983

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

628.260

453.860

293.120

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

1812.180

1219.580

2821.863

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

456.440

392.830

302.450

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

1355.740

826.750

2519.413

 

 

 

 

 

Less

TAX                                                                  (H)

151.430

254.600

795.404

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

1204.310

572.150

1724.009

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

NA

NA

(1225.455)

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Final Dividend

NA

NA

87.914

 

 

Tax on Proposed Final Dividend

NA

NA

11.551

 

 

Transfer to General Reserve

NA

NA

149.194

 

BALANCE CARRIED TO THE B/S

NA

NA

249.895

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

7028.800

5074.750

4151.540

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials and Packing Materials

2765.570

2210.240

1249.000

 

 

Finished Goods

2.100

7.540

 

 

 

Capital Goods

220.360

185.670

166.484

 

TOTAL IMPORTS

2988.030

2403.450

1415.484

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

 

 

 

Basic

36.44

17.31

55.86

 

Diluted

36.44

17.31

49.03

 

 

Particulars

 

 

 

31.03.2013

Sales Turnover (Approximately)

 

 

13250.000

 

 

 

 

 

 

The above information has been parted by Mr. Gaurav Pancholia [Finance Manager]

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

9.60
5.90
21.93

 

 

 
 
 

Net Profit Margin

(PBT/Sales)

(%)

10.96
8.65
32.89

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA
7.96
31.92

 

 

 
 
 

Return on Investment (ROI)

(PBT/Networth)

 

NA
0.20
0.69

 

 

 
 
 

Debt Equity Ratio

(Total Debt/Networth)

 

NA
1.12
1.01

 

 

 
 
 

Current Ratio

(Current Asset/Current Liability)

 

NA
1.77
1.50

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

CURRENT MATURITIES OF LONG TERM DEBT : NOT AVAILABLE

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

--

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

PAN of Proprietor/Partner/Director, if available

No

32]

Date of Birth of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

Yes

34]

External Agency Rating, if available

Yes

 

 

LITIGATION DETAILS

 

 

CS (OS) 2830/2011 and IA No. 18820/2011 (Under Order 39 Rule 1 and 2 CPC)

 

Dong-A Pharma Company Limited …………. Plaintiff

Through: Ms. T. Saukshnya, Adv.

 

Versus

 

Emcure Pharmaceuticals Limited ……..Defendant

Through: Ms. Rajeshwari, Adv.

 

CORAM:

HON’BLE MR. JUSTICE P.K. BHASIN

 

ORDER

02.05.2013

 

At joint request, adjourned to 19th November, 2013.

 

P.K. Bhasin, J.

 

May 02, 2013

 

Neelam

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10388115

08.11.2012

1,104,000,000.00

Axis Bank Limited

2nd Floor-E, Axis House, Bombay Dyeing Mill Compound, P.B. Marg, Worli, Mumbai - 400025, Maharashtra, India

B62610936

2

10366726

26.07.2012

400,000,000.00

Axis Bank Limited

2nd Floor-E, Axis House, Bombay Dyeing Mill Compound, P.B. Marg, Worli, Mumbai – 400025, Maharashtra, India

B44253698

3

10343704

22.03.2012

600,000,000.00

Axis Bank Limited

2nd Floor - E, Axis House, Bombay Dyeing Mill Compound, P. B. Marg, Worli, Mumbai - 400025, Maharashtra, India

B35635275

4

10321886

20.10.2011

340,000,000.00

Housing Development Finance Corporation Limited

Ramon House 169 Backbay Reclamation, H T Parekh Marg, Mumbai - 400020, Maharashtra, India

B27278274

5

10275233

23.03.2011

276,000,000.00

Axis Bank Limited

Credit Management Centre, 214/215, City Mall, Near Pune University, Pune – 411007, Maharashtra, India

B08524878

6

10265084

02.02.2011

1,000,000,000.00

Axis Bank Limited

2nd Floor - E, Axis House, Bombay Dyeing Mill Compound, P. B. Marg, Worli, Mumbai - 400025, Maharashtra, India 

B05724059

7

10228273

10.02.2012 *

6,325,400,000.00

Axis Bank Limited

2nd Floor - E, Axis House, Bombay Dyeing Mill Compound, P. B. Marg, Worli, Mumbai - 400025, Maharashtra, India

B32401408

8

10225052

21.05.2013 *

700,000,000.00

State Bank of India Industrial Finance Branch

Tara Chamber, 2nd Floor, Mariaai Police Chowky, Pune Mumbai Highway, Wakdewadi, Pune -
411003, Maharashtra, India

B77648426

9

10216082

21.05.2013 *

700,000,000.00

State Bank of India

Tara Chambers, Wakdewadi IFB, Pune -
411003, Maharashtra, India

B77645802

 

* Date of charge modification

 

 

UNSECURED LOANS

 

Particulars

31.03.2011

 

31.03.2010

 

 

[Rs. in Millions]

Other Debt Unsecured

285.248

200.119

 

 

 

Total

 

285.248

200.119

 

Note: Trade Deposit (Interest Bearing) (Including interests accrued and due Rs.4.488 Millions)

 

 

 

CONTINGENT LIABILITIES

 

CLAIMS AGAINST THE COMPANY NOT ACKNOWLEDGE AS AT 31ST MARCH, 2012

 

Particulars

31.03.2012

 

31.03.2011

 

[Rs. in Millions]

Sales Tax

97.410

4.680

Excise Matters

38.240

77.83

Others

131.650

--

 

 

FIXED ASSETS:

 

·         Freehold Land

·         Leasehold Land

·         Building

·         Plant and Machinery

·         Electrical Installation

·         Air Handling Equipment

·         Computer

·         Office Equipment

·         Furniture and Fixtures

·         Vehicles

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 59.45

UK Pound

1

Rs. 91.24

Euro

1

Rs. 78.44

 

 

INFORMATION DETAILS

 

Information Gathered by :

PDT

 

 

Report Prepared by :

BVA


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

54

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.